🇺🇸 FDA
Patent

US 10729788

Compositions and methods for treating or ameliorating neuroinflammation, neurodegeneration, neuropathic pain, and migraine

granted A61KA61K38/52A61K48/0058

Quick answer

US patent 10729788 (Compositions and methods for treating or ameliorating neuroinflammation, neurodegeneration, neuropathic pain, and migraine) held by The Regents of the University of California expires Mon Jul 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Aug 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K38/52, A61K48/0058, A61P, A61P25/06